Friday, July 30, 2021

Ocugen, Inc (OCGN) Stock Price Continue to Stumble Amidst IP Uncertainty

Ocugen, Inc. (OCGN) stock prices were down 6.02% as of market close on April 16th, 2021, settling in at USD$5.78. Subsequent pre-market fluctuation saw a dip to USD$5.30, a drop of 7.09%.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Ocugen and Bharat Biotech Collaborate

In December of 2020, Ocugen announced its collaboration with the India-based Bharat Biotech to facilitate the development of Covaxin, a vaccine for the COVID-19 pandemic that has taken the world by storm. Already having been authorized for use in India, Covaxin is setting the stage for its entry into the U.S. market.

Entering the U.S. Market


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


With an efficacy rate of 81% according to the results from a late-stage study, Ocugen is hoping to receive Emergency Use Authorization from the U.S. regulatory authorities, with whom it is currently working with. Should they be granted approval, Ocugen will receive 45% of the profits from Covaxin sales in the U.S.

Hope for U.S. Distribution

While there are competing vaccines that have already entered the U.S. market and boast a higher efficacy rate, the sheer demand for COVID vaccines suggests Covaxin could still capitalize on its potential U.S. presence. This is especially the case since the U.S. government halted the distribution of the COVID vaccine developed by Johnson & Johnson.

Covaxin in India

Given how the world is working towards universal immunization as a means to end the ongoing pandemic, all eyes are on producers of various vaccines for COVID. Covaxin comprises 4 million monthly doses of the cumulative 64 million doses being manufactured in India on a monthly basis. To effectively curb the pandemic through comprehensive vaccinations, sustained production of vaccines is absolutely essential for at least the next several months.

Bureaucratic Red Tape

With the patenting of vaccines conflicting with the need to urgently vaccinate entire populations, there are increasing calls for the WTO to temporarily waive intellectual property rights for COVID-19 vaccines. In 2020, India and South Africa argued for the need to waive certain provisions of the Trade-Related Aspects of Intellectual Property Right (TRIPS) agreement.

Call to Waive TRIPS Agreement

This joint proposal has gained steam since then, with more developing countries opting to co-sponsor the joint proposal. There are indications that the World Trade Organisation’s General Council will convene on May 5th of 2021 to discuss this proposal. On April 16th, 2021, U.S. President Biden was urged by a team of Democratic Senators, headed by Bernie Sanders, to support the proposal to temporarily waive intellectual property barriers that were impeding a resolution to this pandemic.

What does this Mean for Ocugen?

Should this proposal go through, it could be financially subversive for the companies that have developed and patented their COVID vaccines. In ordinary circumstances, the development of a new drug grants the producing company 20 years of security through patenting. With that security in question, some shareholders are having reservations about the profitability of Ocugen over the course of the foreseeable future.

Latest news

KLA Corporation (KLAC) announces new shipments of innovative device

Electronic manufacturing equipment manufacturer KLA Corporation (NASDAQ: KLAC) announced new shipments of its innovative device. It changes one of the major technological processes, and...

Novanta Inc. (NOVT) Acquires Schneider Electric Motion USA (SEM) For $115M Cash

Novanta Inc. (NASDAQ: NOVT) has acquired Schneider Electric Motion USA (SEM), a company that could contribute to its industrial automation development. Novanta Inc. (NOVT) purchased...

What Helped MannKind Corporation (MNKD) Stock Jump 11.6 Percent?

During the trading session on 28 June,2021 MannKind Corporation (NASDAQ: MNKD) advanced 11.60 percent to $5.31.This hike occurred as a result of recent efforts...

Identifying Value and Future Vision in Chewy Inc. (CHWY) Stock

Chewy Inc. (NYSE: CHWY), an online pet product retailer, recently introduced a new service, Connect With a Vet, featuring remote consultations with veterinarians. The...

Related news

KLA Corporation (KLAC) announces new shipments of innovative device

Electronic manufacturing equipment manufacturer KLA Corporation (NASDAQ: KLAC) announced new shipments of its innovative device. It changes one of the major technological processes, and...

Novanta Inc. (NOVT) Acquires Schneider Electric Motion USA (SEM) For $115M Cash

Novanta Inc. (NASDAQ: NOVT) has acquired Schneider Electric Motion USA (SEM), a company that could contribute to its industrial automation development. Novanta Inc. (NOVT) purchased...

What Helped MannKind Corporation (MNKD) Stock Jump 11.6 Percent?

During the trading session on 28 June,2021 MannKind Corporation (NASDAQ: MNKD) advanced 11.60 percent to $5.31.This hike occurred as a result of recent efforts...

Identifying Value and Future Vision in Chewy Inc. (CHWY) Stock

Chewy Inc. (NYSE: CHWY), an online pet product retailer, recently introduced a new service, Connect With a Vet, featuring remote consultations with veterinarians. The...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

1745

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam